Related Experiment Video
Updated: Jun 16, 2026

07:39
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Guidance molecules in lung cancer.
Patrick Nasarre1, Vincent Potiron, Harry Drabkin
1Medical University of South Carolina, Division of Hematology/Oncology, Charleston, SC, USA.
Cell Adhesion & Migration
|February 9, 2010
Summary
Guidance molecules regulate cell movement in development and cancer. This review focuses on their roles in lung cancer, exploring therapeutic targeting strategies.
Area of Science:
- Molecular Biology
- Developmental Biology
- Oncology
Background:
- Guidance molecules control cell migration and tissue development in the nervous system and beyond.
- These molecules are implicated in cancer progression, including tumor angiogenesis and metastasis.
Purpose of the Study:
- To review the functions of guidance molecules in lung development and lung cancer.
- To discuss the potential of targeting guidance molecules therapeutically for cancer treatment.
Main Methods:
- Literature review of guidance molecule families and their receptors.
- Analysis of roles in lung development and cancer biology.
Main Results:
- Five key guidance molecule families (semaphorins, ephrins, netrin, Slit, Notch) and their receptors are detailed.
- Their involvement in lung cancer development, angiogenesis, and metastasis is highlighted.
Conclusions:
- Guidance molecules play critical roles in lung development and cancer.
- Targeting these molecules offers a promising therapeutic avenue for lung cancer.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...